The Integrated 31-Gene Expression Profile Test (i31-GEP) for Cutaneous Melanoma Outperforms the CP-GEP at Identifying Patients Who Can Forego Sentinel Lymph Node Biopsy When Applying NCCN Guidelines. J of Skin 2022, 6 (6), 474-481. https://doi.org/10.25251/skin.6.6.4.